Long-term outcome of thyroid function after amiodarone-induced thyrotoxicosis, as compared to subacute thyroiditis

被引:28
作者
Bogazzi, F.
Dell'Unto, E.
Tanda, M. L.
Tomisti, L.
Cosci, C.
Aghini-Lombardi, F.
Sardella, C.
Pinchera, A.
Bartalena, L.
Martino, E.
机构
[1] Univ Pisa, Osped Cisanello, Dept Endocrinol & Metab, I-56124 Pisa, Italy
[2] Univ Insubria, Dept Clin Med, Varese, Italy
关键词
amiodarone-induced thyrotoxicosis; hyperthyroidism; hypothyroidism; destructive thyroiditis; amiodarone;
D O I
10.1007/BF03344178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Two main forms of amiodarone-induced thyrotoxicosis (AIT) exist: type 1 AIT is a condition of true hyperthyroidism developing in patients with pre-existing thyroid disorders, and usually requires thyroid ablative treatment. On the other hand, type 2 AIT is a form of destructive thyroiditis occurring in normal thyroids, the management of which usually consists in glucocorticoid treatment. Aim: To assess the long-term outcome of thyroid function in a prospective study of type 2 AIT patients, as compared to patients with De Quervain's subacute thyroiditis (SAT). Patients and Methods: Sixty consecutive patients with type 2 AIT were evaluated during oral glucocorticoid treatment (oral prednisone 30 mg/day, gradually tapered and withdrawn over a 3-month period) and followed for 38 4 months (range 672) thereafter. Sixty consecutive patients with SAT, referred to our Institutes during the same period and treated with the same therapeutic schedule, served as controls. Results: Type 2 AIT patients were older (p < 0.0001) and showed a larger male preponderance (M:F 3.6:1 vs 0.5:1, p < 0.0001) than SAT patients. Mean serum free T-4 (FT4) and free T-3 (FT3) concentrations at diagnosis were increased in both conditions, but higher in type 2 AIT than in SAT (FT4 47.6 +/- 18.8 and 29.6 +/- 8.3 pmol/l, respectively, p < 0.0001; FT3 15.4 +/- 7.0 and 11.2 +/- 3.0 pmol/l, respectively, p < 0.001). Correction of thyrotoxicosis was obtained in all patients in both groups, but restoration of euthyroidism occurred earlier in SAT than in type 2 AIT (p=0.006). Ten type 2 AIT patients (17%) and 3 SAT patients (5%, p < 0.03) became permanently hypothyroid after glucocorticoid withdrawal and required levothyroxine replacement. Conclusions: A relevant proportion of type 2 AIT patients develop permanent hypothyroidism after correction of thyrotoxicosis. Thus, periodic surveillance of thyroid status is required after type 2 AIT.
引用
收藏
页码:694 / 699
页数:6
相关论文
共 30 条
[1]   Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association [J].
Bartalena, L ;
Wiersinga, WM ;
Tanda, ML ;
Bogazzi, F ;
Piantanida, E ;
Lai, A ;
Martino, E .
CLINICAL ENDOCRINOLOGY, 2004, 61 (04) :494-502
[2]   Amiodarone-induced thyrotoxicosis: a difficult diagnostic and therapeutic challenge [J].
Bartalena, L ;
Bogazzi, F ;
Martino, E .
CLINICAL ENDOCRINOLOGY, 2002, 56 (01) :23-24
[3]   Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: Results of a prospective study [J].
Bartalena, L ;
Brogioni, S ;
Grasso, L ;
Bogazzi, F ;
Burelli, A ;
Martino, E .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :2930-2933
[4]   Effects of amiodarone administration during pregnancy on neonatal thyroid function and subsequent neurodevelopment [J].
Bartalena, L ;
Bogazzi, F ;
Braverman, LE ;
Martino, E .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2001, 24 (02) :116-130
[5]   Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels:: studies in vivo by color flow doppler sonography [J].
Bogazzi, F ;
Bartalena, L ;
Brogioni, S ;
Burelli, A ;
Manetti, L ;
Tanda, ML ;
Gasperi, M ;
Martino, E .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1999, 140 (05) :452-456
[6]   Preparation with iopanoic acid rapidly controls thyrotoxicosis in patients with amiodarone-induced thyrotoxicosis before thyroidectomy [J].
Bogazzi, F ;
Miccoli, P ;
Berti, P ;
Cosci, C ;
Brogioni, S ;
Aghini-Lombardi, F ;
Materazzi, G ;
Bartalena, L ;
Pinchera, A ;
Braverman, LE ;
Martino, E .
SURGERY, 2002, 132 (06) :1114-1117
[7]   Thyroid color flow doppler sonography and radioiodine uptake in 55 consecutive patients with amiodarone-induced thyrotoxicosis [J].
Bogazzi, F ;
Martino, E ;
Dell'Unto, E ;
Brogioni, S ;
Cosci, C ;
Aghini-Lombardi, F ;
Ceccarelli, C ;
Pinchera, A ;
Bartalena, L ;
Braverman, LE .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2003, 26 (07) :635-640
[8]   Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis [J].
Bogazzi, F ;
Bartalena, L ;
Brogioni, S ;
Mazzeo, S ;
Vitti, P ;
Burelli, A ;
Bartolozzi, C ;
Martino, E .
THYROID, 1997, 7 (04) :541-545
[9]  
BONNYNS M, 1989, ACTA CARDIOL, V44, P235
[10]  
BROUSSOLLE C, 1989, J ENDOCRINOL INVEST, V12, P37